GSK Workers in China Admit to Bribery
Latest FDA and cGMP Compliance News The GSK drama that has been ongoing in China in recent weeks became more serious, as several top executives confessed to crimes of bribery and tax-related crimes. This is according to the Ministry of Public Security in China. The statement from the ministry describes the offenses as very serious […]
Read More »Category : News
Frensenius API Plant Gets FDA Warning Letter
Frensenius Kabi got a warning letter this week from FDA for cGMP violations at its API plant in India. The letter was received on July 1 and was due to an FDA cGMP inspection that was done in Jan. 2013. Several cGMP regulations were broken at the oncolytic API facility that is located in Kalyani, […]
Read More »Category : News
Europe Devises Water Pollution Watch List for Drugs
Latest FDA and cGMP Compliance News Due to growing concern over prescription drugs leaching into water supplies, the European Parliament has put three pharmaceutical compounds on a watch list of pollutants, and these could at some point be put on a top priority list of known, dangerous pollutants. The 3 compounds are: Diclofenac – […]
Read More »Category : News
MHRA Bans Wockhardt from Making Drugs for European Market
Latest FDA and cGMP Compliance News Another drug maker in India is having problems with regulators. This time, the problem is with Wockhardt, and the Indian drug company has now been barred by the Medicines and Healthcare Products Regulatory Agency in the UK from making drugs in Europe. This move comes right after the UK […]
Read More »Category : News
FDA Planning Big Changes to Generic Warning Labels
Latest FDA and cGMP Compliance News With the fast track approval system that Congress set up for generic drugs, people who are hurt by a big name drug can be compensated from the drug company, if they can prove that the drug was dangerous and the label did not have a proper warning. But people […]
Read More »Category : News
Merck Gets Big Preemption Win
Latest FDA and cGMP Compliance News This is a decision that will hearten many in the pharmaceutical industry. This week, a federal court ruled that drugmakers can defend themselves against a lawsuit of product liability by using the concept of preemption – which is the idea that FDA approval of a medical product shall supercede […]
Read More »Category : News
GSK Investigates Illegal Sales Practices for Botox
Latest FDA and cGMP Compliance News GSK is now investigating if doctors were given bribes to prescribe Botox, and if they encouraged 12 employees to utilize private email accounts to cover up the activities. These allegations appear to be from the same anonymous tip that prompted GSK to launch a review last month of Chinese […]
Read More »Category : News
Ranbaxy Plans to Chop Hundreds of Jobs
Latest FDA and cGMP Compliance News As if Ranbaxy Laboratories does not have enough trouble, it looks like more is on the way. The embattled generic manufacturer of pharmaceuticals is in the process of cutting as many as 400 jobs from many divisions, such as R&D and finance, as well as various API units. […]
Read More »Category : News
SEC Charges Insider Trading at Onyx Pharmaceuticals
Latest FDA and cGMP Compliance News About one week after word got out that Onyx Pharmaceuticals turned down a $10 billion offer from Amgen, the SEC filed a suit claiming that several people had committed insider trading and made almost $5 million in illegal profits on an investment of about $300,000. The traders, who are […]
Read More »Category : News
FDA Sends Nasty Warning Letter to Honey Company
Latest FDA and cGMP Compliance News Did you ever think that a jar of honey could be construed to be a drug? If you promote honey for treating allergies and arthritis, as far as the FDA says, you are saying that your honey is a drug and it is going to need to be approved […]
Read More »Category : News
